Skip to Content


Active Substance: mangafodipir trisodium
Common Name: mangafodipir
ATC Code: V08CA05
Marketing Authorisation Holder: GE Healthcare AS
Active Substance: mangafodipir trisodium
Status: Withdrawn
Authorisation Date: 1997-05-22
Therapeutic Area: Magnetic Resonance Imaging
Pharmacotherapeutic Group: Contrast media

Therapeutic Indication

This medicinal product is for diagnostic use only.

Contrast medium for diagnostic magnetic resonance imaging (MRI) for the detection of lesions of the liver suspected to be due to metastatic disease or hepatocellular carcinomas. As an adjunct to MRI to aid in the investigation of focal pancreatic lesions.

The marketing authorisation for Teslascan has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.